Over-The-Counter Drug Industry Growing Rapidly | Be Korea-savvy

Over-The-Counter Drug Industry Growing Rapidly


The market supply of 500 mg Tylenol has been on a steady rise since 2014, and the figure grew from 7 billion won to 8.5 billion won in 2015 before reaching 9.88 billion won in 2016. (Image: Yonhap)

The market supply of 500 mg Tylenol has been on a steady rise since 2014, and the figure grew from 7 billion won to 8.5 billion won in 2015 before reaching 9.88 billion won in 2016. (Image: Yonhap)

SEOUL, Dec. 1 (Korea Bizwire) – The market for over-the-counter drugs sold at convenience stores reached 28.5 billion won last year, with painkiller Tylenol being the most popular item.

According to distribution statistics released by the Health Insurance Review & Assessment Service on Thursday, over 9.8 billion won worth of the caplet type of 500 mg Tylenol was supplied in 2016 alone, becoming the most popular item among the 13 non-prescription drugs sold at convenience stores.

The market supply of 500 mg Tylenol has been on a steady rise since 2014, and the figure grew from 7 billion won to 8.5 billion won in 2015 before reaching 9.88 billion won in 2016.

Following the pain reliever was cold medicine Pancol A and Panpyrin-T, for which market supply amounted to 5.7 billion and 3.2 billion won, respectively.

The 13 over-the-counter drugs sold at convenience stores signify the growth of the market, with total market supply jumping from 19.9 billion won in 2014 to 28.5 billion won in 2016.

Currently, fever reducers and painkillers such as Tylenol and Brufen, cold medicines such as Pancol and Panpyrin, and digestive medicines like Bearse are available at convenience stores in South Korea, after legislation allowing their sale was passed in 2012.

The data also showed a total of 57.1 trillion worth of drugs were distributed in the market, up 8.9 percent from the previous year.

The figure includes all medication traded from wholesalers to retailers before reaching customers.

The South Korean drug industry was estimated at 21.7 trillion won, according to the Health Insurance Review & Assessment Service’s data, which helps experts to better study the South Korean drug market.

Nearly 23.7 trillion won worth of drugs were distributed to medical institutions including hospitals and pharmacies in 2016, up 9.6 percent from the year before, among which nearly 83 percent were covered by the national health insurance.

When broken down in detail, drugs sold at pharmacies accounted for 63.4 percent of the total, while those sold at hospitals accounted for over 35 percent.

Hyunsu Yim (hyunsu@koreabizwire.com)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>